B of A Securities Downgrades Humana to Neutral, Lowers Price Target to $342
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Kevin Fischbeck downgraded Humana (NYSE:HUM) from Buy to Neutral and reduced the price target from $470 to $342, indicating a more cautious outlook on the company's stock.
April 02, 2024 | 5:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana downgraded from Buy to Neutral by B of A Securities, with a significant reduction in price target from $470 to $342.
The downgrade from Buy to Neutral by a major analyst firm, along with a substantial decrease in the price target, suggests a less optimistic view on Humana's future stock performance. This could lead to a negative short-term impact on the stock price as investors adjust their expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100